PMVP Stock Analysis: Buy, Sell, or Hold?
PMVP - PMV Pharmaceuticals, Inc
$1.33
0.03 (2.31%)
▲
5d:
+5.56%
30d:
+0.0%
90d:
+3.91%
WAIT
LOW Confidence
Analysis Updated: Aug 21, 2026 12:00 AM ET
Earnings: Aug 20, 2026
0d
Get Alerted When PMVP Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 MIXED SIGNALS: PMVP shows conflicting indicators. Wait for confirmation before entering.
📊 MIXED SIGNALS: PMVP shows conflicting indicators. Wait for confirmation before entering.
In-depth Analysis How we analyze
Valuation Analysis: PMVP is currently trading at $1.33, which is considered extended relative to its 30-day fair value range of $1.15 to $1.31.
Technical Outlook: Technically, PMVP is in a strong uptrend. The price is approaching resistance at $1.35. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: PMVP scores 23/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $4.00 (+200.8%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, PMVP is in a strong uptrend. The price is approaching resistance at $1.35. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: PMVP scores 23/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $4.00 (+200.8%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$1.15 -
$1.31
Company Quality Score
40/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
26.3%
All Signals
- BEARISH: Price extended above range
- BEARISH: Weak technical setup (23/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 200.8% below Wall St target ($4.00)
- WARNING: Composite score 40/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$1.15 -
$1.31
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$1.16
Resistance Level
$1.35
Current Trend
Strong Uptrend
Technical data as of
Aug 21, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-1.16
Wall Street Target
$4.00
(+200.8%)
Share & Embed Analysis
Last updated: August 24, 2026 7:00 AM ET
Data refreshes hourly during market hours. Next update: 8:00 AM
Data refreshes hourly during market hours. Next update: 8:00 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is PMVP showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ALNY
Alnylam Pharmaceuticals … |
STRONG BUY
30 analysts |
$370 | 42 HOLD |
|
CYTK
Cytokinetics Inc |
STRONG BUY
21 analysts |
$110 | 66 BUY |
|
INSM
Insmed Inc |
STRONG BUY
21 analysts |
$200 | 41 HOLD |
|
CRSP
Crispr Therapeutics AG |
BUY
28 analysts |
$88 | 41 HOLD |
|
ASND
Ascendis Pharma AS |
STRONG BUY
16 analysts |
$313 | 51 HOLD |
